Oxidase
There is disclosed an oxidase gene useful for the diagnosis of RA and the screening of a substance for the treatment of RA and/or a substance for the treatment of osteoarthritis. Also, an inspection method useful as a diagnosis method for RA is disclosed. Additionally, there is disclosed a method for screening a substance for the treatment of RA and/or a substance for the treatment of osteoarthritis, using the aforementioned novel oxidase gene. Also disclosed is a method for producing a pharmaceutical composition for the treatment of RA and/or the treatment of osteoarthritis which comprises an inhibitor of the aforementioned oxidase, which is obtainable by the aforementioned screening method, as an active ingredient.
1. An isolated polypeptide consisting of the amino acid sequence of SEQ ID NO:2.
2. A screening method, comprising:
(1) contacting a test substance with a cell expressing a recombinant polypeptide, said polypeptide consisting of the amino acid sequence of SEQ ID NO:2, wherein said polypeptide produces O 2 − , increases expression of Tumor Necrosis Factor-α (TNF-α), and/or increases expression of cyclooxygenase-2 (COX-2);
(2) determining whether said test substance inhibits at least one of: (i) said production of O 2 − , (ii) said increase in expression of TNF-α, and (iii) said increase in expression of COX-2; and
(3) selecting a substance capable of inhibiting at least one of: (i) said production of O 2 − , (ii) said increase in expression of TNF-α, and (iii) said increase in expression of COX-2.